This website is intended for patients prescribed Emgality® (galcanezumab) in the UK only. Side effects reporting and safety information can be found at the bottom of the page.

About Emgality®
How to use Emgality®
FAQ’s
Resources

Calm mode

Calm mode

About Emgality®
How to use Emgality®
FAQ’s
Resources

Month: February 2025

Welcome to WordPress. This is your first post. Edit or delete it, then start writing!

Search

Recent Posts

Hello world!
Hello world!

Recent Comments

A WordPress Commenter on Hello world!
A WordPress Commenter on Hello world!

Archives

June 2025
February 2025

Categories

Uncategorized

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card scheme at https://yellowcard.mhra.gov.uk By reporting side effects you can help provide more information on the safety of this medicine.

© 2025 Lilly and Organon. All rights reserved. EMGALITY, LILLY and the LILLY logo are registered trademarks of Eli Lilly and Company. ORGANON and the ORGANON logo are registered trademarks of N.V. Organon.

Cookie Preferences
Terms of Use
Cookie Policy
Privacy Policy

Leaving Emgality.co.uk

You are now Leaving the Emgality^® website. We are unable to verify any information on third party sites.

Proceed Cancel

Healthcare Professionals

If you are a UK Healthcare Professional and would like more information on Emgaility®, including how to unlock this website to support your patients with using Emgality® please contact your customer representative.

Contact Us Cancel